BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20736378)

  • 21. Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities.
    Filbin MG; Dabral SK; Pazyra-Murphy MF; Ramkissoon S; Kung AL; Pak E; Chung J; Theisen MA; Sun Y; Franchetti Y; Sun Y; Shulman DS; Redjal N; Tabak B; Beroukhim R; Wang Q; Zhao J; Dorsch M; Buonamici S; Ligon KL; Kelleher JF; Segal RA
    Nat Med; 2013 Nov; 19(11):1518-23. PubMed ID: 24076665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis.
    Vitucci M; Karpinich NO; Bash RE; Werneke AM; Schmid RS; White KK; McNeill RS; Huff B; Wang S; Van Dyke T; Miller CR
    Neuro Oncol; 2013 Oct; 15(10):1317-29. PubMed ID: 23814263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MAGI3 Suppresses Glioma Cell Proliferation via Upregulation of PTEN Expression.
    Ma Q; Zhang Y; Meng R; Xie KM; Xiong Y; Lin S; He ZL; Tao T; Yang Y; Zhao JZ; He JQ
    Biomed Environ Sci; 2015 Jul; 28(7):502-9. PubMed ID: 26248734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic Smurf1 promotes PTEN wild-type glioblastoma growth by mediating PTEN ubiquitylation.
    Xia Q; Zhang H; Zhang P; Li Y; Xu M; Li X; Li X; Dong L
    Oncogene; 2020 Sep; 39(36):5902-5915. PubMed ID: 32737433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
    Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
    Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylation.
    Peterziel H; Müller J; Danner A; Barbus S; Liu HK; Radlwimmer B; Pietsch T; Lichter P; Schütz G; Hess J; Angel P
    Neuro Oncol; 2012 Apr; 14(4):426-39. PubMed ID: 22394497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PI3K/Akt and Stat3 signaling regulated by PTEN control of the cancer stem cell population, proliferation and senescence in a glioblastoma cell line.
    Moon SH; Kim DK; Cha Y; Jeon I; Song J; Park KS
    Int J Oncol; 2013 Mar; 42(3):921-8. PubMed ID: 23314408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K/AKT/NFkB pathway in lung cancer cells.
    Akca H; Demiray A; Tokgun O; Yokota J
    Lung Cancer; 2011 Sep; 73(3):302-9. PubMed ID: 21333374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation.
    Oh YS; Heo K; Kim EK; Jang JH; Bae SS; Park JB; Kim YH; Song M; Kim SR; Ryu SH; Kim IH; Suh PG
    Exp Mol Med; 2017 Jul; 49(7):e351. PubMed ID: 28684865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.
    Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA
    Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1.
    Qian X; Li X; Shi Z; Xia Y; Cai Q; Xu D; Tan L; Du L; Zheng Y; Zhao D; Zhang C; Lorenzi PL; You Y; Jiang BH; Jiang T; Li H; Lu Z
    Mol Cell; 2019 Nov; 76(3):516-527.e7. PubMed ID: 31492635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells.
    Guo P; Nie Q; Lan J; Ge J; Qiu Y; Mao Q
    Biochem Biophys Res Commun; 2013 Nov; 441(1):186-90. PubMed ID: 24140063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
    Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
    FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN dephosphorylates AKT to prevent the expression of GLUT1 on plasmamembrane and to limit glucose consumption in cancer cells.
    Phadngam S; Castiglioni A; Ferraresi A; Morani F; Follo C; Isidoro C
    Oncotarget; 2016 Dec; 7(51):84999-85020. PubMed ID: 27829222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.
    Vaquero J; Nguyen Ho-Bouldoires TH; Clapéron A; Fouassier L
    Oncogene; 2017 Jun; 36(22):3067-3079. PubMed ID: 28068322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
    Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
    Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.
    Chen Q; Weng HY; Tang XP; Lin Y; Yuan Y; Li Q; Tang Z; Wu HB; Yang S; Li Y; Zhao XL; Fu WJ; Niu Q; Feng H; Zhang X; Wang Y; Bian XW; Yao XH
    J Pathol; 2019 Feb; 247(2):266-278. PubMed ID: 30357833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NHERF1/EBP50 is a new marker in colorectal cancer.
    Hayashi Y; Molina JR; Hamilton SR; Georgescu MM
    Neoplasia; 2010 Dec; 12(12):1013-22. PubMed ID: 21170265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma.
    Wiencke JK; Zheng S; Jelluma N; Tihan T; Vandenberg S; Tamgüney T; Baumber R; Parsons R; Lamborn KR; Berger MS; Wrensch MR; Haas-Kogan DA; Stokoe D
    Neuro Oncol; 2007 Jul; 9(3):271-9. PubMed ID: 17504928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
    Panner A; Crane CA; Weng C; Feletti A; Fang S; Parsa AT; Pieper RO
    Cancer Res; 2010 Jun; 70(12):5046-53. PubMed ID: 20484045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.